The purpose of this study is to find out whether people who have had thyroid cancer develop resistance to treatment with thyroid hormones after having received high doses of thyroid drugs for many years.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
TRH administration will be given as a 200-mcg single IV bolus on Day 1 and Day 5.
Patients maintenance dose of levothyroxine will be taken throughout the study. On Day 1 and Day 5, the levothyroxine will be taken after the TRH test is complete. On Days 2- 4, the levothyroxine will be taken in the morning.
Administer standardized Hypothyroidism QOL questionnaire.
change in peak TSH levels
in response to TRH stimulation between day 1 (baseline) and day 5 after three days of high dose LT3 treatment.
Time frame: day 5
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.